Tomáš Šimurda/LinkedIn
Jun 16, 2026, 13:49
Tomáš Šimurda: Fibromics Team Secures EHA Innovation Grant for Innovative Research
Tomáš Šimurda, Hematologist at National Center of Hemostasis and Thrombosis, University Lecturer at Jessenius Faculty of Medicine in Martin, shared a post on LinkedIn:
“Honored to receive the 2026 European Hematology Association (EHA) Innovation Grant.
This recognition reflects the strength of international collaboration within the Fibromics consortia together with Alessandro Casini, Giancarlo Castaman, Saskia Schols, and Maartje van den Biggelaar.
Grateful to EHA for supporting innovative research in hematology and to all colleagues and collaborators who contribute to this journey.”
Stay updated with Hemostasis Today.
-
Jun 16, 2026, 13:56Christina (Tina) P.: Can Vitamin K Help Stabilize Your INR?
-
Jun 16, 2026, 13:47Kaziwa Rasoul: Understanding Thrombosis in PNH
-
Jun 16, 2026, 13:46Fiona Robinson: New Ways to Engage Young People with Bleeding Disorders on the Upcoming NBDF Wednesday Webinar
-
Jun 16, 2026, 13:31Updated Recommendations for Pediatric Antithrombotic Therapies – JTH
-
Jun 16, 2026, 13:28Vidya Rajbhoj: Sharing Our Work on Developing an FND Pathway for Stroke Patients at FNDS 2026
-
Jun 16, 2026, 13:21Vinu Rajendran: Donor Appreciation Evening – World Blood Donor Day 2026
-
Jun 16, 2026, 13:21Robin Wells: Coming Together o Support the American Heart Association’s Detroit Heart and Stroke Walk
-
Jun 16, 2026, 13:07Dimitris Nikolopoulos: Summer Vacation Can Increase Your Risk for Deep Vein Thrombosis
-
Jun 16, 2026, 13:06Toyosi Onwuemene: Why Anticoagulation Errors Persist Despite Strong Protocols